Catherine W M ONG ; Paul A TAMBYAH
Annals of the Academy of Medicine, Singapore 2011;40(3):113-115
Antitubercular Agents ; economics ; therapeutic use ; Directly Observed Therapy ; Drug Resistance, Multiple, Bacterial ; Humans ; Singapore ; epidemiology ; Tuberculosis, Multidrug-Resistant ; drug therapy ; economics